3144 Consensus to clinic: enhancing diagnostics for posterior cortical atrophy

Background/ObjectivesNearly thirty thousand Australians under the age of 65 live with dementia. Posterior Cortical Atrophy (PCA) is one form of young onset atypical dementia, often caused by Alzheimer disease. Due to its rarity, atypical phenotype and young onset, the diagnosis is often missed for y...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ neurology open 2024-08, Vol.6 (Suppl 1), p.A43-A44
Hauptverfasser: Christensen, Maja, Darby, David, Mercier, Laure Le, Brodtmann, Amy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background/ObjectivesNearly thirty thousand Australians under the age of 65 live with dementia. Posterior Cortical Atrophy (PCA) is one form of young onset atypical dementia, often caused by Alzheimer disease. Due to its rarity, atypical phenotype and young onset, the diagnosis is often missed for years. A consensus expert opinion diagnostic framework was created in 2017 to reduce delays to diagnosis. We aimed to test the validity of this framework in a real-world PCA population.MethodsWe completed a retrospective audit of Eastern Cognitive Disorders Clinic (ECDC) patients with a clinician-determined final diagnosis of PCA (N=32) 2008–2022: age at diagnosis, time to diagnosis and the clinical, cognitive, and neuro-imaging features. We compared our patients’ presentations with the core cognitive features included in the framework and their presence at first assessment.Results Thirty (93.8%) ECDC clinician diagnosed PCA patients fulfilled the criteria: cognitive features correlated well with the framework for the top four features (visuo-spatial and -perceptual deficits, simultanagnosia, constructional apraxia). 100% of patients had MRI brain, but only 38% were reported as PCA; 84% had FDG-PET brain with 59% reported as PCA. Most (28, 87.5%) presentations were in keeping with a PCA-pure syndrome. Three patients met criteria for PCA-plus-CBS and one for PCA-plus-DLB. Average delay to diagnosis was 4 years with mean symptom onset at age 59 years.ConclusionOur patients’ cognitive features closely aligned with the consensus framework, corroborating its real-world applicability. Neuroradiological reporting was identified as a key challenge. This represents new Australian data on PCA syndromic diagnosis.
ISSN:2632-6140
DOI:10.1136/bmjno-2024-ANZAN.122